Trial NCT00883116

View at ClinicalTrials.gov 
Org. Study IDs: CA163-196
Secondary IDs: 2008-007167-16

Last trial update was posted on 2017-03-09

MeSH Interventions

Albumin-Bound Paclitaxel Doxorubicin Paclitaxel

MeSH Conditions

Endometrial Neoplasms

Other Conditions

Endometrial Cancer

Stopping Reasons

Interim analysis results showed that ixabepilone did not improve survival compared with control chemotherapies.

Limitations And Caveats

This study was terminated per Data Monitoring Committee. Results from an interim analysis showed that there was no favorable benefit/risk ratio with ixabepilone and that ixabepilone did not improve survival compared with control chemotherapies.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID